Evidence map›Paper›PMID 38364956›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.

Michelle C Starr, Katja M Gist, Huaiyu Zang, Nicholas J Ollberding, Shanthi Balani, Andrea Cappoli, Eileen Ciccia, Catherine Joseph, Aadil Kakajiwala, Aaron Kessel and 11 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Neonatal continuous kidney replacement therapy.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 4 countries.

Michelle C StarrDivision of Nephrology, Pediatric and Adolescent Comparative Effectiveness Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Katja M GistDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Huaiyu ZangDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Nicholas J OllberdingDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Shanthi BalaniDivision of Nephrology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Andrea CappoliDivision of Nephrology, Department of Pediatrics, Children Hospital Bambino Gesù, Rome, Italy.
Eileen CicciaDivision of Nephrology, Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri.
Catherine JosephDivision of Nephrology, Department of Pediatrics, Texas Children's Hospital, Houston, Texas.
Aadil KakajiwalaDivision of Critical Care Medicine and Nephrology, Department of Pediatrics, Children's National Hospital, Washington, DC.
Aaron KesselDivision of Critical Care, Department of Pediatrics, Cohen Children's Medical Center, Zucker School of Medicine, New Hyde Park.
Melissa Muff-LuettDivision of Nephrology, Department of Pediatrics, University of Nebraska Medical Center, Children's Hospital & Medical Center, Omaha, NE.
María J Santiago LozanoDivision of Intensive Care, Department of Pediatrics, Gregorio Marañón University Hospital; School of Medicine, Madrid, Spain.
Matthew PintoDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York.
Stephanie ReynaudDivision of Pediatric and Neonatal Critical Care, Department of Pediatrics, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Sonia SolomonDivision of Pediatric Nephrology, Department of Pediatrics, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York.
Cara SlagleDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Rachana SrivastavaDivision of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, Los Angeles, California.
Weiwen V ShihDivision of Nephrology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
Tennille WebbDivision of Nephrology, Department of Pediatrics, Children's of Alabama and University of Alabama at Birmingham, Birmingham, Alabama.
Shina MenonDivision of Nephrology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington; Division of Nephrology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California. Electronic address: shinam@stanford.edu.
Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative
Cincinnati Children's Hospital Medical Center · USWestchester Medical Center · USChildren's Hospital & Medical Center · USSeattle Children's Hospital · USSt. Louis Children's Hospital · USTexas Children's Hospital · USBambino Gesù Children's Hospital · ITChildren's Hospital Colorado · USChildren's National · USChildren's of Alabama · USCohen Children's Medical Center · USHospital General Universitario Gregorio Marañón · ESIndiana University School of MedicineMattel Children's Hospital · USUniversité Paris-Saclay · FRUniversity of Minnesota · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
CTSA K12 Program at Indiana UniversityK12TR004415 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI SAMIR KUMAR GUPTA · 2023 to 2026
$3.4M
Developing a Precision Medicine Approach to Pediatric Sepsis-Associated Acute Kidney Injury: Identification of Unique Subphenotypes and Strategies for Bedside ImplementationK23GM151444 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Natalja L. Stanski · 2023 to 2026
$769k
Improving the prediction of bronchopulmonary dysplasia by identifying kidney-based risk factorsK23HL168362 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Michelle C Starr · 2024 to 2026
$547k
Consensus Workshop to Address Kidney Health in High-Risk Neonatal Intensive Care Unit GraduatesR13DK137550 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI STARR, MICHELLE C · 2023 to 2023
$13k
NCATS NIH HHS K12 TR004415NCATS NIH HHS UL1 TR001425NHLBI NIH HHS K23 HL168362NIDDK NIH HHS R13 DK137550NIGMS NIH HHS K23 GM151444
6 · The paper itself

Abstract

RATIONALE &

objectiveThere are limited studies describing the epidemiology and outcomes in children and young adults receiving continuous kidney replacement therapy (CKRT). We aimed to describe associations between patient characteristics, CKRT prescription, and survival. STUDY

designRetrospective multicenter cohort study. SETTING &

participants980 patients aged from birth to 25 years who received CKRT between 2015 and 2021 at 1 of 32 centers in 7 countries participating in WE-ROCK (Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Diseases). EXPOSURE: CKRT for acute kidney injury or volume overload. OUTCOMES: Death before intensive care unit (ICU) discharge. ANALYTICAL APPROACH: Descriptive statistics.

resultsMedian age was 8.8 years (IQR, 1.6-15.0), and median weight was 26.8 (IQR, 11.6-55.0) kg. CKRT was initiated a median of 2 (IQR, 1-6) days after ICU admission and lasted a median of 6 (IQR, 3-14) days. The most common CKRT modality was continuous venovenous hemodiafiltration. Citrate anticoagulation was used in 62%, and the internal jugular vein was the most common catheter placement location (66%). 629 participants (64.1%) survived at least until ICU discharge. CKRT dose, filter type, and anticoagulation were similar in those who did and did not survive to ICU discharge. There were apparent practice variations by institutional ICU size. LIMITATIONS: Retrospective design; limited representation from centers outside the United States.

conclusionsIn this study of children and young adults receiving CKRT, approximately two thirds survived at least until ICU discharge. Although variations in dialysis mode and dose, catheter size and location, and anticoagulation were observed, survival was not detected to be associated with these parameters. PLAIN-LANGUAGE SUMMARY: In this large contemporary epidemiological study of children and young adults receiving continuous kidney replacement therapy in the intensive care unit, we observed that two thirds of patients survived at least until ICU discharge. However, patients with comorbidities appeared to have worse outcomes. Compared with previously published reports on continuous kidney replacement therapy practice, we observed greater use of continuous venovenous hemodiafiltration with regional citrate anticoagulation.

Indexed as

Acute Kidney InjuryContinuous Renal Replacement TherapyAdolescentAdultChildChild, PreschoolCohort StudiesFemaleHumansInfantInfant, NewbornMaleRetrospective StudiesSurvival RateYoung Adultacute kidney injuryContinuous kidney replacement therapydatabasefluid overloadintensive care unitpediatrictechniqueWE-ROCK

Identifiers

PMID38364956
PMCPMC11324858
OpenAlexW4391847893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.